Loading…

Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease

There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both h...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of disease 2025-01, Vol.204, p.106752, Article 106752
Main Authors: Cepeda, Carlos, Holley, Sandra M., Barry, Joshua, Oikonomou, Katerina D., Yazon, Vannah-Wila, Peng, Allison, Argueta, Deneen, Levine, Michael S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c344t-b6209d2ba931a541df0d0fff830afc52b65e4330a67f82bc27d38466c5291c8b3
container_end_page
container_issue
container_start_page 106752
container_title Neurobiology of disease
container_volume 204
creator Cepeda, Carlos
Holley, Sandra M.
Barry, Joshua
Oikonomou, Katerina D.
Yazon, Vannah-Wila
Peng, Allison
Argueta, Deneen
Levine, Michael S.
description There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both humans and animal models of HD. However, a concurrent study of cortical and striatal development in a genetic model of HD is still lacking. Here we report significant alterations of corticostriatal development in the R6/2 mouse model of juvenile HD. We examined wildtype (WT) and R6/2 mice at postnatal (P) days 7, 14, and 21. Morphological examination demonstrated early structural and cellular alterations reminiscent of malformations of cortical development, and ex vivo electrophysiological recordings of cortical pyramidal neurons (CPNs) demonstrated significant age- and genotype-dependent changes of intrinsic membrane and synaptic properties. In general, R6/2 CPNs had reduced cell membrane capacitance and increased input resistance (P7 and P14), along with reduced frequency of spontaneous excitatory and inhibitory synaptic events during early development (P7), suggesting delayed cortical maturation. This was confirmed by increased occurrence of GABAA receptor-mediated giant depolarizing potentials at P7. At P14, the rheobase of CPNs was significantly reduced, along with increased excitability. Altered membrane and synaptic properties of R6/2 CPNs recovered progressively, and by P21 they were similar to WT CPNs. In striatal medium-sized spiny neurons (MSNs), a different picture emerged. Intrinsic membrane properties were relatively normal throughout development, except for a transient increase in membrane capacitance at P14. The first alterations in MSNs synaptic activity were observed at P14 and consisted of significant deficits in GABAergic inputs, however, these also were normalized by P21. In contrast, excitatory inputs began to decrease at this age. We conclude that the developing HD brain is capable of compensating for early developmental abnormalities and that cortical alterations precede and are a main contributor of striatal changes. Addressing cortical maldevelopment could help prevent or delay disease manifestations. [Display omitted] •The development of cortical and striatal projection neurons in R6/2 Huntington's disease mice is abnormal.•Abnormalities of cortical projection neurons occur earlier and are more severe than those of striatal projection neuron
doi_str_mv 10.1016/j.nbd.2024.106752
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f3ac089decaf4e6d877173f479aa7d0f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969996124003541</els_id><doaj_id>oai_doaj_org_article_f3ac089decaf4e6d877173f479aa7d0f</doaj_id><sourcerecordid>3146568398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-b6209d2ba931a541df0d0fff830afc52b65e4330a67f82bc27d38466c5291c8b3</originalsourceid><addsrcrecordid>eNp9kUGPFCEQhYnRuOPqD_BiuOmlZ6GhoYknM1ndTTYxMRq9ERqKlU53MwI9if9exl736AVSxauv8ngIvaZkTwkVV-N-Gdy-JS2vtZBd-wTtKFFdozr24ynaESVUo5SgF-hFziMhlHZKPkcXTAnOlVQ79P0QUwk25pKCKWbCs5kcnGCKxxmWgsOCy0_AX8RVi-e4ZqingwlHj8f1BEuYAN-sSwnLfYnL24xdyGAyvETPvJkyvHq4L9G3j9dfDzfN3edPt4cPd41lnJdmEC1Rrh2MYtR0nDpPHPHe94wYb7t2EB1wVgshfd8OtpWO9VyI-qSo7Qd2iW43rotm1McUZpN-62iC_tuI6V6bs8EJtGfGkl45sMZzEK6XkkrmuVTGyLq1st5trGOKv1bIRc8hW5gms0C1rhnlohM9U32V0k1qU8w5gX9cTYk-Z6NHXbPR52z0lk2defOAX4cZ3OPEvzCq4P0mgPphpwBJZxtgseBCAluqo_Af_B8yQZ8-</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146568398</pqid></control><display><type>article</type><title>Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease</title><source>ScienceDirect Journals</source><creator>Cepeda, Carlos ; Holley, Sandra M. ; Barry, Joshua ; Oikonomou, Katerina D. ; Yazon, Vannah-Wila ; Peng, Allison ; Argueta, Deneen ; Levine, Michael S.</creator><creatorcontrib>Cepeda, Carlos ; Holley, Sandra M. ; Barry, Joshua ; Oikonomou, Katerina D. ; Yazon, Vannah-Wila ; Peng, Allison ; Argueta, Deneen ; Levine, Michael S.</creatorcontrib><description>There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both humans and animal models of HD. However, a concurrent study of cortical and striatal development in a genetic model of HD is still lacking. Here we report significant alterations of corticostriatal development in the R6/2 mouse model of juvenile HD. We examined wildtype (WT) and R6/2 mice at postnatal (P) days 7, 14, and 21. Morphological examination demonstrated early structural and cellular alterations reminiscent of malformations of cortical development, and ex vivo electrophysiological recordings of cortical pyramidal neurons (CPNs) demonstrated significant age- and genotype-dependent changes of intrinsic membrane and synaptic properties. In general, R6/2 CPNs had reduced cell membrane capacitance and increased input resistance (P7 and P14), along with reduced frequency of spontaneous excitatory and inhibitory synaptic events during early development (P7), suggesting delayed cortical maturation. This was confirmed by increased occurrence of GABAA receptor-mediated giant depolarizing potentials at P7. At P14, the rheobase of CPNs was significantly reduced, along with increased excitability. Altered membrane and synaptic properties of R6/2 CPNs recovered progressively, and by P21 they were similar to WT CPNs. In striatal medium-sized spiny neurons (MSNs), a different picture emerged. Intrinsic membrane properties were relatively normal throughout development, except for a transient increase in membrane capacitance at P14. The first alterations in MSNs synaptic activity were observed at P14 and consisted of significant deficits in GABAergic inputs, however, these also were normalized by P21. In contrast, excitatory inputs began to decrease at this age. We conclude that the developing HD brain is capable of compensating for early developmental abnormalities and that cortical alterations precede and are a main contributor of striatal changes. Addressing cortical maldevelopment could help prevent or delay disease manifestations. [Display omitted] •The development of cortical and striatal projection neurons in R6/2 Huntington's disease mice is abnormal.•Abnormalities of cortical projection neurons occur earlier and are more severe than those of striatal projection neurons.•Huntington's disease brains are capable of correcting some early developmental abnormalities via compensatory mechanisms.</description><identifier>ISSN: 0969-9961</identifier><identifier>ISSN: 1095-953X</identifier><identifier>EISSN: 1095-953X</identifier><identifier>DOI: 10.1016/j.nbd.2024.106752</identifier><identifier>PMID: 39644979</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cerebral Cortex - growth &amp; development ; Cerebral Cortex - pathology ; Cerebral Cortex - physiopathology ; Corpus Striatum - pathology ; Development ; Disease Models, Animal ; Ex vivo electrophysiology ; Huntingtin Protein - genetics ; Huntingtin Protein - metabolism ; Huntington Disease - genetics ; Huntington Disease - pathology ; Huntington Disease - physiopathology ; Juvenile Huntington's disease ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Pyramidal Cells - pathology ; R6/2 mouse ; Synaptic activity</subject><ispartof>Neurobiology of disease, 2025-01, Vol.204, p.106752, Article 106752</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c344t-b6209d2ba931a541df0d0fff830afc52b65e4330a67f82bc27d38466c5291c8b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0969996124003541$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39644979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cepeda, Carlos</creatorcontrib><creatorcontrib>Holley, Sandra M.</creatorcontrib><creatorcontrib>Barry, Joshua</creatorcontrib><creatorcontrib>Oikonomou, Katerina D.</creatorcontrib><creatorcontrib>Yazon, Vannah-Wila</creatorcontrib><creatorcontrib>Peng, Allison</creatorcontrib><creatorcontrib>Argueta, Deneen</creatorcontrib><creatorcontrib>Levine, Michael S.</creatorcontrib><title>Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease</title><title>Neurobiology of disease</title><addtitle>Neurobiol Dis</addtitle><description>There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both humans and animal models of HD. However, a concurrent study of cortical and striatal development in a genetic model of HD is still lacking. Here we report significant alterations of corticostriatal development in the R6/2 mouse model of juvenile HD. We examined wildtype (WT) and R6/2 mice at postnatal (P) days 7, 14, and 21. Morphological examination demonstrated early structural and cellular alterations reminiscent of malformations of cortical development, and ex vivo electrophysiological recordings of cortical pyramidal neurons (CPNs) demonstrated significant age- and genotype-dependent changes of intrinsic membrane and synaptic properties. In general, R6/2 CPNs had reduced cell membrane capacitance and increased input resistance (P7 and P14), along with reduced frequency of spontaneous excitatory and inhibitory synaptic events during early development (P7), suggesting delayed cortical maturation. This was confirmed by increased occurrence of GABAA receptor-mediated giant depolarizing potentials at P7. At P14, the rheobase of CPNs was significantly reduced, along with increased excitability. Altered membrane and synaptic properties of R6/2 CPNs recovered progressively, and by P21 they were similar to WT CPNs. In striatal medium-sized spiny neurons (MSNs), a different picture emerged. Intrinsic membrane properties were relatively normal throughout development, except for a transient increase in membrane capacitance at P14. The first alterations in MSNs synaptic activity were observed at P14 and consisted of significant deficits in GABAergic inputs, however, these also were normalized by P21. In contrast, excitatory inputs began to decrease at this age. We conclude that the developing HD brain is capable of compensating for early developmental abnormalities and that cortical alterations precede and are a main contributor of striatal changes. Addressing cortical maldevelopment could help prevent or delay disease manifestations. [Display omitted] •The development of cortical and striatal projection neurons in R6/2 Huntington's disease mice is abnormal.•Abnormalities of cortical projection neurons occur earlier and are more severe than those of striatal projection neurons.•Huntington's disease brains are capable of correcting some early developmental abnormalities via compensatory mechanisms.</description><subject>Animals</subject><subject>Cerebral Cortex - growth &amp; development</subject><subject>Cerebral Cortex - pathology</subject><subject>Cerebral Cortex - physiopathology</subject><subject>Corpus Striatum - pathology</subject><subject>Development</subject><subject>Disease Models, Animal</subject><subject>Ex vivo electrophysiology</subject><subject>Huntingtin Protein - genetics</subject><subject>Huntingtin Protein - metabolism</subject><subject>Huntington Disease - genetics</subject><subject>Huntington Disease - pathology</subject><subject>Huntington Disease - physiopathology</subject><subject>Juvenile Huntington's disease</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Pyramidal Cells - pathology</subject><subject>R6/2 mouse</subject><subject>Synaptic activity</subject><issn>0969-9961</issn><issn>1095-953X</issn><issn>1095-953X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kUGPFCEQhYnRuOPqD_BiuOmlZ6GhoYknM1ndTTYxMRq9ERqKlU53MwI9if9exl736AVSxauv8ngIvaZkTwkVV-N-Gdy-JS2vtZBd-wTtKFFdozr24ynaESVUo5SgF-hFziMhlHZKPkcXTAnOlVQ79P0QUwk25pKCKWbCs5kcnGCKxxmWgsOCy0_AX8RVi-e4ZqingwlHj8f1BEuYAN-sSwnLfYnL24xdyGAyvETPvJkyvHq4L9G3j9dfDzfN3edPt4cPd41lnJdmEC1Rrh2MYtR0nDpPHPHe94wYb7t2EB1wVgshfd8OtpWO9VyI-qSo7Qd2iW43rotm1McUZpN-62iC_tuI6V6bs8EJtGfGkl45sMZzEK6XkkrmuVTGyLq1st5trGOKv1bIRc8hW5gms0C1rhnlohM9U32V0k1qU8w5gX9cTYk-Z6NHXbPR52z0lk2defOAX4cZ3OPEvzCq4P0mgPphpwBJZxtgseBCAluqo_Af_B8yQZ8-</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Cepeda, Carlos</creator><creator>Holley, Sandra M.</creator><creator>Barry, Joshua</creator><creator>Oikonomou, Katerina D.</creator><creator>Yazon, Vannah-Wila</creator><creator>Peng, Allison</creator><creator>Argueta, Deneen</creator><creator>Levine, Michael S.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>202501</creationdate><title>Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease</title><author>Cepeda, Carlos ; Holley, Sandra M. ; Barry, Joshua ; Oikonomou, Katerina D. ; Yazon, Vannah-Wila ; Peng, Allison ; Argueta, Deneen ; Levine, Michael S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-b6209d2ba931a541df0d0fff830afc52b65e4330a67f82bc27d38466c5291c8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Animals</topic><topic>Cerebral Cortex - growth &amp; development</topic><topic>Cerebral Cortex - pathology</topic><topic>Cerebral Cortex - physiopathology</topic><topic>Corpus Striatum - pathology</topic><topic>Development</topic><topic>Disease Models, Animal</topic><topic>Ex vivo electrophysiology</topic><topic>Huntingtin Protein - genetics</topic><topic>Huntingtin Protein - metabolism</topic><topic>Huntington Disease - genetics</topic><topic>Huntington Disease - pathology</topic><topic>Huntington Disease - physiopathology</topic><topic>Juvenile Huntington's disease</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Pyramidal Cells - pathology</topic><topic>R6/2 mouse</topic><topic>Synaptic activity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cepeda, Carlos</creatorcontrib><creatorcontrib>Holley, Sandra M.</creatorcontrib><creatorcontrib>Barry, Joshua</creatorcontrib><creatorcontrib>Oikonomou, Katerina D.</creatorcontrib><creatorcontrib>Yazon, Vannah-Wila</creatorcontrib><creatorcontrib>Peng, Allison</creatorcontrib><creatorcontrib>Argueta, Deneen</creatorcontrib><creatorcontrib>Levine, Michael S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neurobiology of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cepeda, Carlos</au><au>Holley, Sandra M.</au><au>Barry, Joshua</au><au>Oikonomou, Katerina D.</au><au>Yazon, Vannah-Wila</au><au>Peng, Allison</au><au>Argueta, Deneen</au><au>Levine, Michael S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease</atitle><jtitle>Neurobiology of disease</jtitle><addtitle>Neurobiol Dis</addtitle><date>2025-01</date><risdate>2025</risdate><volume>204</volume><spage>106752</spage><pages>106752-</pages><artnum>106752</artnum><issn>0969-9961</issn><issn>1095-953X</issn><eissn>1095-953X</eissn><abstract>There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both humans and animal models of HD. However, a concurrent study of cortical and striatal development in a genetic model of HD is still lacking. Here we report significant alterations of corticostriatal development in the R6/2 mouse model of juvenile HD. We examined wildtype (WT) and R6/2 mice at postnatal (P) days 7, 14, and 21. Morphological examination demonstrated early structural and cellular alterations reminiscent of malformations of cortical development, and ex vivo electrophysiological recordings of cortical pyramidal neurons (CPNs) demonstrated significant age- and genotype-dependent changes of intrinsic membrane and synaptic properties. In general, R6/2 CPNs had reduced cell membrane capacitance and increased input resistance (P7 and P14), along with reduced frequency of spontaneous excitatory and inhibitory synaptic events during early development (P7), suggesting delayed cortical maturation. This was confirmed by increased occurrence of GABAA receptor-mediated giant depolarizing potentials at P7. At P14, the rheobase of CPNs was significantly reduced, along with increased excitability. Altered membrane and synaptic properties of R6/2 CPNs recovered progressively, and by P21 they were similar to WT CPNs. In striatal medium-sized spiny neurons (MSNs), a different picture emerged. Intrinsic membrane properties were relatively normal throughout development, except for a transient increase in membrane capacitance at P14. The first alterations in MSNs synaptic activity were observed at P14 and consisted of significant deficits in GABAergic inputs, however, these also were normalized by P21. In contrast, excitatory inputs began to decrease at this age. We conclude that the developing HD brain is capable of compensating for early developmental abnormalities and that cortical alterations precede and are a main contributor of striatal changes. Addressing cortical maldevelopment could help prevent or delay disease manifestations. [Display omitted] •The development of cortical and striatal projection neurons in R6/2 Huntington's disease mice is abnormal.•Abnormalities of cortical projection neurons occur earlier and are more severe than those of striatal projection neurons.•Huntington's disease brains are capable of correcting some early developmental abnormalities via compensatory mechanisms.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39644979</pmid><doi>10.1016/j.nbd.2024.106752</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0969-9961
ispartof Neurobiology of disease, 2025-01, Vol.204, p.106752, Article 106752
issn 0969-9961
1095-953X
1095-953X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f3ac089decaf4e6d877173f479aa7d0f
source ScienceDirect Journals
subjects Animals
Cerebral Cortex - growth & development
Cerebral Cortex - pathology
Cerebral Cortex - physiopathology
Corpus Striatum - pathology
Development
Disease Models, Animal
Ex vivo electrophysiology
Huntingtin Protein - genetics
Huntingtin Protein - metabolism
Huntington Disease - genetics
Huntington Disease - pathology
Huntington Disease - physiopathology
Juvenile Huntington's disease
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Pyramidal Cells - pathology
R6/2 mouse
Synaptic activity
title Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A01%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corticostriatal%20maldevelopment%20in%20the%20R6/2%20mouse%20model%20of%20juvenile%20Huntington's%20disease&rft.jtitle=Neurobiology%20of%20disease&rft.au=Cepeda,%20Carlos&rft.date=2025-01&rft.volume=204&rft.spage=106752&rft.pages=106752-&rft.artnum=106752&rft.issn=0969-9961&rft.eissn=1095-953X&rft_id=info:doi/10.1016/j.nbd.2024.106752&rft_dat=%3Cproquest_doaj_%3E3146568398%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-b6209d2ba931a541df0d0fff830afc52b65e4330a67f82bc27d38466c5291c8b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3146568398&rft_id=info:pmid/39644979&rfr_iscdi=true